Team:Paris/Perspectives

From 2008.igem.org

(Difference between revisions)
(B.Artificial virus factory)
 
(28 intermediate revisions not shown)
Line 1: Line 1:
{{Paris/Menu}}
{{Paris/Menu}}
 +
{{Paris/Header|Perspectives}}
-
<font color=red>''Un petit texte pour expliquer la motivation de cette page''  ne serait-ce que tout simplement:
 
-
On this page we report some possible uses of the FIFO device in synthetic applications.
 
-
General comment: I am not at all against an explorative, speculative section. But it's purpose must be clear very clearly focussed on the interest of the FIFO for putative applications. Discuss each time why the FIFO could be especially interesting for your application. This must be very clear in order for this section to fulfill it's purpose.</font>
+
As for the flagella biosynthesis, our FIFO could be useful for many '''bottom-up assembled molecular machines''' that needs to be assembled in a precise order.
 +
Moreover, as we will show on an example, the FIFO could also be useful in many '''biosynthetic pathways''' subject to competitive alternative pathways and for wich intermediate products must be avoided.
 +
We will develop below two examples: type III secretion injectisome and PHA biosynthesis pathway.
 +
== Example 1: type III secretion injectisome ==
 +
The injectisome is a complex nanomachine that allows bacteria to deliver protein effector across eucaryotic cellular membranes.
 +
The injectisome consists of a basal structure, which resembles the basal structure of the flagellum, surmounted by either a needle, a needle and a filament or a long pilus.
 +
[[Image:injectisome.JPG]]
-
== Metabolic engineering of polyhydroxyalkanoate biosynthesis pathways ==
 
-
Human overpopulation combined with the current lifestyle urges the rational, efficient, and sustainable use of natural resources to produce environmentally friendly plastic materials such as polyhydroxyalkanoic acids (PHAs), whose production/degradation cycle reduces undesirable wastes and emissions.
 
-
Our  study is a new metabolic strategy to generate PHA-hyperproducer strains, that have the properties to be a sequential metabolic pathway, we believe the sequential expression  may increases the  production of purified PHA.
 
-
Our strategy consists on replacing  the RFP,CFP and YFP genes by the PhaA ,PhaB and PhaC genes in our final system (containing oscillation,FIFO,synchronisation modules).
+
The injectisome is related to the flagellum genetically. Studies show that a core of eight proteins share significant similarity with components of the flagellum. From this studies, we can expect that the genes expression is ruled by a  sequential FIFO order so we can express it with our bacteriO'clock system .
 +
Moreover, the injectisome will find a lot of applications for example ,bacteria that express this kinds of structure  could :
 +
* induce apoptosis of Eukaryote cells so we can developed  by our system new kinds of  in-vivo compatible anticancer therapy,
 +
* be a new way to liberate substances produced by bacteria (see bioplastic application).
-
This strategy is more efficient than a constitutive activation for 3 main reasons:
+
In conclusion, our BacteriO'Clock can be used in a lot of new applications like for instance, bottom-up molecular machines self-assembly or new kinds of optimized chemoreactor.
-
*First, in this application the NADPH, which is a cellular metastable  fuel, is used by the PhaB to  synthesize bioplastic. This molecule is very important for many metabolic pathways in bacteria. A NADPH recuperation step is then needed to ensure other metabolic activities to go on. We can then make the hypothesis that if the PhaB is always  activated the bacteria will get exhausted and die quickly. In our system, the bacteria will have a NADPH recuperation step, this is why we hope bacteria will live more than in an usual chemoreactor.
+
-
*Secondly, we hope by the order of the FIFO to make a synchronized and sequential expression in order to increase the rate of the PHA biosynthesis.
+
== Example 2: metabolic engineering of polyhydroxyalkanoate biosynthesis pathways ==
 +
Human overpopulation combined with the current lifestyle urges the rational, efficient, and sustainable use of natural resources to produce environmentally friendly plastic materials.
 +
One illustrative example is polyhydroxyalkanoic acids (PHAs), whose production/degradation cycle reduces undesirable wastes and emissions.
 +
The biosynthesis of this polymer is currently subject to intensive work.
 +
It consists in expressing in appropriate quantities 3 enzymes  PhaA ,PhaB and PhaC that sequentially process AcetoacetylcoA into its final product PHA.
 +
This biosynthesis os subjected to 2 constraints :
 +
* Intermediate products of this pathway are used in alternatives competing metabolic pathways,
 +
* Only the final product is of interest,so that all intermediates products need to be transformed into PHA.
-
*Third, as the quality of the bioplastic increases with time, we could predict the quality of the final  product since we would know the duration of a production cycle thanks to the periodicity of our system.
+
[[Image:PHA.jpg|center]]
-
<span style="color: blue"> Again, you cannot just state this boldly without constructing an argument. </span>
+
-
<span style="color: blue"> You never explain why your system is better than simply expressing all the genes continuously at a lower level </span>
+
Two strategies are commonly used in bioengineering of metabolic pathways :
 +
* Sequential expression of enzymes involved in the pathways,
 +
* Or constitutive expressions of all enzymes.
 +
Because of the above  mentioned limitations, none of these approaches are adapted here .
 +
Using the sequential expression, intermediate products would accumulate and thus be consumed by competing pathways.
 +
Using the constitutive expression a mixture of final and intermediate product would necessarily be obtained.
-
<span style="color: blue"> More generally, on this whole page: We don't expect you to give very detailed projects. You just need to give simple ideas for which the interest of the FIFO seems obvious (or at least you need to try making it seem obvious). We are not so much interested in the precise mechanisms or genes involved, but rather in the principles that make your projects interesting.</span>
+
Our FIFO could be useful here.  
 +
Indeed a FIFO expression pattern is intermediate between a purely sequential and a purely constitutive expression.
 +
At some point all enzymes are presents ( no accumulation of intermediate products ) and during the last step only the last enzyme (PhC) is presents ( all intermediate products are consumed).
 +
 
 +
Moreover, the fact that our system oscillate could provide to the cell a metabolic recovering phase.
-
[[Image:PHA.jpg|center]]
 
== Bibliography ==
== Bibliography ==
-
* Folding DNA to create nanoscale shapes and patterns
+
 
-
Paul W. K. Rothemund
+
* The type III secretion injectisome  Guy R.Cornelis Nature reviews
-
* Design of DNA origami
+
 
-
Paul W. K. Rothemund
+
* Process design for microbial plastic factories: metabolic engineering of polyhydroxyalkanoates
-
* An autonomous polymerization motor powered by DNA hybridization.
+
Ilana S Aldor and Jay D Keasling
-
Suvir Venkataraman, Robert M. Dirks, Paul W. K. Rothemund, Erik Winfree, Niles A. Pierce.
+
Department of Chemical Engineering, 201 Gilman Hall, University of California, Berkeley, 94720-1462, USA
-
* Catalyzed Relaxation of a Metastable DNA Fuel.
+
23 September 2003
-
Georg Seelig, Bernard Yurke, Erik Winfree.
+
 
 +
* PHA synthase engineering toward superbiocatalysts for custom-made biopolymers.
 +
Nomura CT, Taguchi S.
 +
Department of Chemistry, State University of New York - College of Environmental Science and Forestry, 121 Jahn Laboratory, Syracuse, NY 13210, USA.

Latest revision as of 04:52, 30 October 2008

Perspectives



As for the flagella biosynthesis, our FIFO could be useful for many bottom-up assembled molecular machines that needs to be assembled in a precise order. Moreover, as we will show on an example, the FIFO could also be useful in many biosynthetic pathways subject to competitive alternative pathways and for wich intermediate products must be avoided. We will develop below two examples: type III secretion injectisome and PHA biosynthesis pathway.


Example 1: type III secretion injectisome

The injectisome is a complex nanomachine that allows bacteria to deliver protein effector across eucaryotic cellular membranes. The injectisome consists of a basal structure, which resembles the basal structure of the flagellum, surmounted by either a needle, a needle and a filament or a long pilus.

Injectisome.JPG


The injectisome is related to the flagellum genetically. Studies show that a core of eight proteins share significant similarity with components of the flagellum. From this studies, we can expect that the genes expression is ruled by a sequential FIFO order so we can express it with our bacteriO'clock system . Moreover, the injectisome will find a lot of applications for example ,bacteria that express this kinds of structure could :

  • induce apoptosis of Eukaryote cells so we can developed by our system new kinds of in-vivo compatible anticancer therapy,
  • be a new way to liberate substances produced by bacteria (see bioplastic application).

In conclusion, our BacteriO'Clock can be used in a lot of new applications like for instance, bottom-up molecular machines self-assembly or new kinds of optimized chemoreactor.

Example 2: metabolic engineering of polyhydroxyalkanoate biosynthesis pathways

Human overpopulation combined with the current lifestyle urges the rational, efficient, and sustainable use of natural resources to produce environmentally friendly plastic materials. One illustrative example is polyhydroxyalkanoic acids (PHAs), whose production/degradation cycle reduces undesirable wastes and emissions. The biosynthesis of this polymer is currently subject to intensive work. It consists in expressing in appropriate quantities 3 enzymes PhaA ,PhaB and PhaC that sequentially process AcetoacetylcoA into its final product PHA. This biosynthesis os subjected to 2 constraints :

  • Intermediate products of this pathway are used in alternatives competing metabolic pathways,
  • Only the final product is of interest,so that all intermediates products need to be transformed into PHA.
PHA.jpg

Two strategies are commonly used in bioengineering of metabolic pathways :

  • Sequential expression of enzymes involved in the pathways,
  • Or constitutive expressions of all enzymes.

Because of the above mentioned limitations, none of these approaches are adapted here . Using the sequential expression, intermediate products would accumulate and thus be consumed by competing pathways. Using the constitutive expression a mixture of final and intermediate product would necessarily be obtained.

Our FIFO could be useful here. Indeed a FIFO expression pattern is intermediate between a purely sequential and a purely constitutive expression. At some point all enzymes are presents ( no accumulation of intermediate products ) and during the last step only the last enzyme (PhC) is presents ( all intermediate products are consumed).

Moreover, the fact that our system oscillate could provide to the cell a metabolic recovering phase.


Bibliography

  • The type III secretion injectisome Guy R.Cornelis Nature reviews
  • Process design for microbial plastic factories: metabolic engineering of polyhydroxyalkanoates

Ilana S Aldor and Jay D Keasling Department of Chemical Engineering, 201 Gilman Hall, University of California, Berkeley, 94720-1462, USA 23 September 2003

  • PHA synthase engineering toward superbiocatalysts for custom-made biopolymers.

Nomura CT, Taguchi S. Department of Chemistry, State University of New York - College of Environmental Science and Forestry, 121 Jahn Laboratory, Syracuse, NY 13210, USA.